Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-08-15
2006-08-15
Gupta, Anish (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S184100, C424S235100, C424S239100
Reexamination Certificate
active
07091176
ABSTRACT:
A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.
REFERENCES:
patent: 2373454 (1945-04-01), Bumy et al.
patent: 2719102 (1955-09-01), Baldwin
patent: 3132995 (1964-05-01), Berger et al.
patent: 4234566 (1980-11-01), Packman et al.
patent: 4713240 (1987-12-01), Wilkins et al.
patent: 4720494 (1988-01-01), Felger et al.
patent: 4932936 (1990-06-01), Dykstra et al.
patent: 5053005 (1991-10-01), Borodic
patent: 5055291 (1991-10-01), Lam et al.
patent: 5055302 (1991-10-01), Laties et al.
patent: 5183462 (1993-02-01), Borodic
patent: 5437291 (1995-08-01), Pasricha et al.
patent: 5696077 (1997-12-01), Johnson et al.
patent: 5766605 (1998-06-01), Sanders et al.
patent: 6113915 (2000-09-01), Aoki et al.
patent: 6235289 (2001-05-01), Aoki et al.
patent: 6333037 (2001-12-01), Aoki et al.
patent: 6372226 (2002-04-01), Aoki et al.
patent: 6375988 (2002-04-01), Suzuki et al.
patent: 6500436 (2002-12-01), Donovan
patent: 6887476 (2005-05-01), Aoki et al.
patent: 1-287041 (1989-11-01), None
patent: 2-213 (1990-01-01), None
patent: WO95/28171 (1995-10-01), None
patent: WO9528171 (1995-10-01), None
File scisearch on STN. AN No. 93:162872. Price et al. ‘A Comparative Study of Tear Secretion in Blepharospasm and Hemifacial Spasm Patients Treated with Botulinum Toxin’, J. of Clin. Neuro-Opthalmology, vol. 13, No. 1, pp. 67-71. Mar. 1993.
File Caplus on STN. DN No. 105:220509. Knight, D.E. ‘Botulinum Toxin Types A, B and D Inhibit Catecholamine Secretion From Bovine Adrenal Medullary Cells’, FEBS. Lett. vol. 207, No. 2, pp. 222-226, 1986.
Kondo et al. ‘Modification of the Action of Pentagastrin on Acid Secretion by Botulinum Toxin’, Experientia. vol. 33, No. 6, pp. 750-751, 1977.
Patent Abstract of Japan; Patent No. 1992-283510; published Oct. 8, 1992.
Patent Abstract of Japan; Patent No. 1993-186362; published Jul. 27, 1993.
Patent Abstract of Japan; Patent No. 1993-186364; published Jul. 27, 1993.
Patent Abstract of Japan; Patent No. 1997-309843; published Dec. 2, 1997.
Zhong SP; “Biodegradation of Hyaluronic Acid Derivatives by Hyaluronidase”; National Library of Medicine; Department of Clinical Engineering; University of Liverpool; UK; Apr. 1994; pp. 1.
Grusser Von O-J, Die ersten systematischen Beschreibungen und tierexperiemtellen Untersuchungen des Botulisums, Sudhoffa Archiv (1986), 70(2), 167-186. English translation attached.
Kerner, J. Das Fettgift oder die fettsaure und ihre wirkungen auf den thierischen organismus, ein beytrag zur untersuchung des in verdorbenen wursten giftig wirkenden stoffes. Stuttgart und Tubingen: Cotta, 368 pages (1822); English translation of table of contents and of Chapter 8 enclosed.
Bergmann, MD, et al.;Selective Degeneration of Sudomotor Fibers in Ross Syndrome and Successful Treatment of Compensatory Hyperhidrosis with Botulinum Toxin; Muscle&Nerve; Dec. 1998, pp. 1790-1793.
Glogau, Richard MD;Botulinum A Neurotoxin for Axillary Hyperhidrosis; Dermatol Surg.; Aug. 1998; 24(8), pp. 817-819.
Heneson, Nancy;Deadly Toxin Calms Excited Muscles; New Scientist, Dec. 8, 1990, p. 24.
Kaszynski, Edwin, et al.;Mouse Foot Screen for the Inhibition of Sweating by Anticholinergic Drugs; The Journal of Investiagative Dermatology, 1974, vol. 62, pp. 510-513.
Naumann, M., et al.;Botulinum Toxin for Focal Hyperhidrosis: Technical Considerations and Improvements in Applications; British Journal of Dermatology, 1998, 139, pp. 1123-1124.
Naumann, Markus, et al.;Botulinum Toxin for Palmar Hyperhidrosis; Lancet, Jan. 25, 1997, vol. 349.
Naumann, Markus, et al.;Focal Hyperhidrosis; Arch Dermatol, Mar. 1998, vol. 134, pp. 301-304.
Naver, Hans, et al.;The Treatment of Focal Hyperhidrosis with Botulinum Toxin; European Journal of Neurology, 1997, vol. 4, Suppl 2, pp. S75-S79.
Odderson, Ib, MD;Axillary Hyperhidrosis: Treatment with Botulinum Toxin A; Arch Phys Med. Rehabil., Mar. 1998, vol. 79, pp. 350-352.
Schantz, Edward, et al.;Properties and Use of Botulinum Toxin and Other Microbial Neurotoxins in Medicine; Microbiological Reviews, Mar. 1992, pp. 80-95.
Schnider, P., et al.;Double-Blind Trial of Botulinum A Toxin for the Treatment of Focal Hyperhidrosis of the Palms; British Journal of Dermatology, 1997, 136(4), pp. 548-552.
Shelley, W. B., et al.;Botulinum Toxin Therapy for Palmar Hyperhidrosis; Journal of the American Academy of Dermatology, Feb. 1998, 38 (2 Part 1), pp. 227-229.
Stevens, Leslie M., et al.;Development and Properties of the Secretory Response in Rats sweat Glands: Relationship to the Induction of Cholinergic Function in Sweat Gland Innervation; Developmental Biology, 1987, 123, pp. 179-190.
Purngvarin et al; J. Med. Assoc. Thai. (Apr. 1992) 75 (4) 199-203.
Correspondence dated Dec. 10, 1991 Between William C. Shepherd and Ira Sanders.
Correspondence dated Apr. 13, 1992 Between Ira Sanders and Angelika S. Aswad Regarding “Animal Study”.
Partial Correspondence Dated Apr. 24, 1992 Between Angelika S. Asward and Dr. Sanders Regarding Botulinum Toxin to Decrease Salivary Flow.
Ambache, J. Physiol. (1951) 113, 1-17.
Brin. Arch. De Neurobiol. 54. Supl. 3 (7-23) 1991.
Ambache, N.;A Further Survey of the Action of Clostridium Botulinum Toxin upon Different Types of Autonomic Nerve Fibre; J. Physiol.; 1951; 113:1-17.
Jenzer, G., et al.;Type B Botulism, Report on Mild Courses with Predominantly Autonomic Nervous Impairment; Schweiz. Med. Wschr.; 104, 685-693; 1974. (English translation also enclosed.).
Aoki K. Roger
Carlson Steven R.
Grayston Michael W.
Leon Judith M.
Allergan Inc.
Donovan Stephen
Gupta Anish
LandOfFree
Methods for treating arthritis pain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating arthritis pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating arthritis pain will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3712846